HDT Bio receives Emergency Use Approval for Covid-19 vaccine in India
Gemcovac became the first saRNA vaccine to obtain approval for use in humans in India.

Gemcovac became the first saRNA vaccine to obtain approval for use in humans in India.
The latest approval is based on findings from the Phase II ZUMA-5 trial in 122 relapsed or refractory FL patients.
The vaccine doses for Taiwan would be the first shipment to a nation participating in the COVAX Facility.
The EC approval is based on positive findings from the Phase II GEOMETRY mono-1 clinical trial of Tabrecta.
The latest approval is based on findings from seven trials of the vaccine in infants, children and adolescents.
In a Phase III trial, treatment with Voxzogo offered transient declines in blood pressure.
The EUA is based on findings from a Phase II/III trial that comprised 4,526 children aged six months to four…
With the latest development, more than 100 individuals in England and Wales will be eligible to receive imlifidase.
Thank you for subscribing to Pharmaceutical Technology